|
Volumn 37, Issue 8, 2012, Pages 879-881
|
Reaction to biological drugs: Infliximab for the treatment of toxic epidermal necrolysis subsequently triggering erosive lichen planus
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETAMETHASONE SODIUM PHOSPHATE;
BICARBONATE;
CLOBETASOL PROPIONATE;
IMMUNOGLOBULIN G;
INFLIXIMAB;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISOLONE;
SALAZOSULFAPYRIDINE;
TACROLIMUS;
ADULT;
ADVERSE OUTCOME;
ARTICLE;
BLISTER;
CASE REPORT;
CUSHINGOID SYNDROME;
DISEASE SEVERITY;
DRUG SAFETY;
FEMALE;
HISTOLOGY;
HUMAN;
HUMAN TISSUE;
INTENSIVE CARE;
LICHEN PLANUS;
MOUTH ULCER;
PHYSICAL EXAMINATION;
PRIORITY JOURNAL;
RESPIRATORY DISTRESS;
RHEUMATOID ARTHRITIS;
SCORING SYSTEM;
SKIN BIOPSY;
SKIN NECROSIS;
TOXIC EPIDERMAL NECROLYSIS;
VULVA PRURITUS;
ADULT;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTIBODIES, MONOCLONAL;
BIOLOGICAL THERAPY;
DRUG ERUPTIONS;
EPIDERMAL NECROLYSIS, TOXIC;
FEMALE;
HUMANS;
LICHEN PLANUS;
LICHEN PLANUS, ORAL;
TUMOR NECROSIS FACTOR-ALPHA;
VULVAR DISEASES;
|
EID: 84870060397
PISSN: 03076938
EISSN: 13652230
Source Type: Journal
DOI: 10.1111/j.1365-2230.2012.04357.x Document Type: Article |
Times cited : (33)
|
References (10)
|